Literature DB >> 11575161

Initiation factor eIF2 alpha phosphorylation in stress responses and apoptosis.

M J Clemens1.   

Abstract

The alpha subunit of polypeptide chain initiation factor eIF2 can be phosphorylated by a number of related protein kinases which are activated in response to cellular stresses. Physiological conditions which result in eIF2 alpha phosphorylation include virus infection, heat shock, iron deficiency, nutrient deprivation, changes in intracellular calcium, accumulation of unfolded or denatured proteins and the induction of apoptosis. Phosphorylated eIF2 acts as a dominant inhibitor of the guanine nucleotide exchange factor eIF2B and prevents the recycling of eIF2 between successive rounds of protein synthesis. Extensive phosphorylation of eIF2 alpha and strong inhibition of eIF2B activity can result in the downregulation of the overall rate of protein synthesis; less marked changes may lead to alterations in the selective translation of alternative open reading frames in polycistronic mRNAs, as demonstrated in yeast. These mechanisms can provide a signal transduction pathway linking eukaryotic cellular stress responses to alterations in the control of gene expression at the translational level.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11575161     DOI: 10.1007/978-3-662-09889-9_3

Source DB:  PubMed          Journal:  Prog Mol Subcell Biol        ISSN: 0079-6484


  72 in total

1.  Inhibition of the protein kinase PKR by the internal ribosome entry site of hepatitis C virus genomic RNA.

Authors:  Jashmin Vyas; Androulla Elia; Michael J Clemens
Journal:  RNA       Date:  2003-07       Impact factor: 4.942

2.  Defects in translational regulation mediated by the alpha subunit of eukaryotic initiation factor 2 inhibit antiviral activity and facilitate the malignant transformation of human fibroblasts.

Authors:  Darren J Perkins; Glen N Barber
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

3.  XBP-1 is required for biogenesis of cellular secretory machinery of exocrine glands.

Authors:  Ann-Hwee Lee; Gerald C Chu; Neal N Iwakoshi; Laurie H Glimcher
Journal:  EMBO J       Date:  2005-12-15       Impact factor: 11.598

4.  Direct ribosomal binding by a cellular inhibitor of translation.

Authors:  Daniel A Colón-Ramos; Christina L Shenvi; Douglas H Weitzel; Eugene C Gan; Robert Matts; Jamie Cate; Sally Kornbluth
Journal:  Nat Struct Mol Biol       Date:  2006-01-22       Impact factor: 15.369

5.  Fibronectin controls cap-dependent translation through beta1 integrin and eukaryotic initiation factors 4 and 2 coordinated pathways.

Authors:  Chiara Gorrini; Fabrizio Loreni; Valentina Gandin; Leonardo A Sala; Nahum Sonenberg; Pier Carlo Marchisio; Stefano Biffo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-16       Impact factor: 11.205

6.  Hsp70 associates with Rictor and is required for mTORC2 formation and activity.

Authors:  Jheralyn Martin; Janine Masri; Andrew Bernath; Robert N Nishimura; Joseph Gera
Journal:  Biochem Biophys Res Commun       Date:  2008-05-27       Impact factor: 3.575

7.  Polysome trafficking of transcripts and microRNAs in regenerating liver after partial hepatectomy.

Authors:  Betsy T Kren; Phillip Y-P Wong; Akira Shiota; Xiaoxiao Zhang; Yan Zeng; Clifford J Steer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-09-24       Impact factor: 4.052

Review 8.  Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.

Authors:  N Muge Kuyumcu-Martinez; Thomas A Cooper
Journal:  Prog Mol Subcell Biol       Date:  2006

9.  Persistent redistribution of poly-adenylated mRNAs correlates with translation arrest and cell death following global brain ischemia and reperfusion.

Authors:  J T Jamison; F Kayali; J Rudolph; M Marshall; S R Kimball; D J DeGracia
Journal:  Neuroscience       Date:  2008-04-01       Impact factor: 3.590

10.  The roles of nitric oxide synthase and eIF2alpha kinases in regulation of cell cycle upon UVB-irradiation.

Authors:  Lei Wang; Yan Liu; Shiyong Wu
Journal:  Cell Cycle       Date:  2010-01-05       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.